International Journal of Cardiology: Heart & Vasculature (Aug 2021)

Visually estimated coronary artery calcium score improves SPECT-MPI risk stratification

  • Cvetan Trpkov,
  • Alexei Savtchenko,
  • Zhiying Liang,
  • Patrick Feng,
  • Danielle A. Southern,
  • Stephen B. Wilton,
  • Matthew T. James,
  • Erin Feil,
  • Ilias Mylonas,
  • Robert J.H. Miller

Journal volume & issue
Vol. 35
p. 100827

Abstract

Read online

Aims: Computed tomographic attenuation correction (CTAC) scans for single photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) may reveal coronary artery calcification. The independent prognostic value of a visually estimated coronary artery calcium score (VECACS) from these low-dose, non-gated scans is not established. Methods & Results: VECACS was evaluated in 4,720 patients undergoing SPECT-MPI with CTAC using a 4-point scale. Major adverse cardiac events (MACE) were defined as all-cause mortality, acute coronary syndrome, or revascularization > 90 days after SPECT-MPI. Independent associations with MACE were determined with multivariable Cox proportional hazards analyses adjusted for age, sex, past medical history, perfusion findings, and left ventricular ejection fraction. During a median follow up of 2.9 years (interquartile range 1.8 – 4.2), 494 (10.5%) patients experienced MACE. Compared to absent VECACS, patients with increased VECACS were more likely to experience MACE (all log-rank p < 0.001), and findings were similar when stratified by normal or abnormal perfusion. Multivariable analysis showed an increased MACE risk associated with VECACS categories of equivocal (adjusted hazard ratio [HR] 2.54, 95% CI 1.45–4.45, p = 0.001), present (adjusted HR 2.44, 95% CI 1.74–3.42, p < 0.001) and extensive (adjusted HR 3.47, 95% CI 2.41–5.00, p < 0.001) compared to absent. Addition of VECACS to the multivariable model improved risk classification (continuous net reclassification index 0.207, 95% CI 0.131 – 0.310). Conclusion: VECACS was an independent predictor of MACE in this large SPECT-MPI patient cohort. VECACS from CTAC can be used to improve risk stratification with SPECT-MPI without additional radiation.

Keywords